7 Medical Claims That Now Require Manual Review

In the fast-paced world of digital healthcare, patients have grown accustomed to “real-time” adjudication, where a claim is processed and a copay is determined before they even leave the doctor's office. However, in 2026, a significant percentage of medical claims hit a speed bump. To combat fraud and manage the rising costs of complex therapies, insurance payers have recalibrated their algorithms to flag specific categories of care for “Manual Clinical Review.”

This shift means that instead of being instantly approved by a computer, your claim is pulled out of the digital pile and placed in a queue to be read by a human nurse or medical coder. For the patient, this transition from “Auto-Adjudication” to “Manual Review” manifests as a mysterious delay. Your online portal shows the claim as “Pending” or “In Process” for weeks, often leading to anxiety about whether the bill will eventually be covered. Understanding which services trigger this pause can help you prepare for the delay and gather the necessary documentation before the inevitable request for records arrives. Here are the seven medical claims that are almost guaranteed to trigger a manual review in 2026.

1. Genetic and Molecular Testing Panels

The single most scrutinized category in 2026 is genetic testing. Following a massive wave of fraud involving “cancer screening” telemarketing schemes, insurers have slammed the brakes on automated payments for these expensive lab tests. According to federal fraud alerts regarding genetic testing, payers are now manually reviewing claims to ensure the specific gene panel ordered matches the patient's family history and diagnosis codes perfectly.

If your doctor orders a broad “pan-cancer” screening instead of a targeted test for a specific mutation, the claim will likely sit in review while the insurer requests the doctor's clinical notes to prove medical necessity. This delay is designed to stop “rubber stamp” prescriptions, but for legitimate patients, it means waiting months to know if their $4,000 test is covered.

2. Level 5 Emergency Room Visits

If you visit the ER for a severe issue but are discharged the same day, your claim is a prime target for a “Clinical Validation” review. Insurers like Aetna and Cigna have implemented strict downcoding policies that flag Level 5 (high severity) claims for manual audit if the patient was not admitted to the hospital.

Instead of automatically paying the Level 5 rate, the insurer pauses the claim to see if a human auditor can downgrade it to a cheaper Level 3 or 4 based on the discharge summary. This process often leaves the patient with an uncertain “Patient Responsibility” amount for months while the hospital appeals the decision.

3. Modifier 25 and 59 “Unbundling”

One of the most technical triggers for a manual review involves the use of Modifier 25 (separate E/M visit) and Modifier 59 (distinct procedure). These codes allow doctors to bill for two services during one visit, such as a checkup and a mole removal. However, due to rampant overuse, 2026 coding updates have made these modifiers a primary target for “Pre-Payment Review.”

Claims carrying these modifiers are frequently pulled to verify that the doctor actually performed two distinct services rather than just unbundling a single interaction to get paid twice. If your explanation of benefits (EOB) is delayed, it is often because the insurer is reading the notes to see if that “separate checkup” really happened.

4. Inpatient Rehabilitation Admissions

Getting approved for a stay at an acute rehabilitation facility after a stroke or surgery is becoming significantly harder due to manual “Pre-Payment” reviews. Insurers are strictly enforcing criteria outlined in the CMS FY 2026 Inpatient Rehabilitation Facility Final Rule.

Payers are no longer taking the hospital's word for it; they are manually reviewing the daily therapy logs from the first few days of the stay. If the notes show the patient was too tired to complete their mandatory three hours of therapy, the insurer may retroactively deny the entire admission as “Custodial Care,” forcing the facility to bill the patient or appeal.

5. Biologic Drug Wastage (The JZ Modifier)

The high cost of biologic drugs—often thousands of dollars per vial—has led to strict new rules regarding “wastage.” If a patient needs 400mg of a drug but it comes in single-use 500mg vials, the remaining 100mg is discarded. Under the 2026 Medicare Physician Fee Schedule, providers must use specific codes (like the JZ modifier) to attest that they discarded the excess.

Insurance auditors are manually reviewing these claims to ensure the amount billed as “wasted” matches the drug's package size and the patient's weight-based dose, ensuring clinics aren't “harvesting” leftovers while billing for full vials.

6. Remote Physiologic Monitoring (RPM)

Remote Patient Monitoring has exploded in popularity, but 2026 brings a crackdown on “auto-pilot” billing. Insurers are auditing claims for codes like CPT 99454 (device supply) to ensure patients are actually using the devices.

UnitedHealthcare's 2026 policy updates specifically restrict coverage for RPM in cases of simple hypertension or Type 2 diabetes, requiring manual review to prove the monitoring is preventing hospitalization. If you have a connected blood pressure cuff, your monthly claim may be held up while the insurer checks the data logs to confirm you are uploading readings frequently enough to justify the cost.

7. Unlisted Procedure Codes

With the rapid advancement of AI and robotic surgery, doctors are frequently using “Unlisted Codes” (e.g., CPT 64999) for new technologies that don't have a permanent billing code yet. By definition, an unlisted code cannot be auto-adjudicated because it has no set price.

Every single one requires a human claim adjustor to read the operative report and determine a fair price. This manual pricing process can delay a bill by 60 to 90 days, leaving the patient in limbo while the insurer and provider haggle over the value of the new procedure.

Don't Panic, But Don't Ignore It

If your claim is stuck in “Manual Review,” it does not necessarily mean it will be denied; it means it is being watched. The most important step you can take is to monitor your insurance portal weekly. If the status remains “Pending” for more than 30 days, call your provider—not the insurance company. Ask the billing department: “Have you received a request for medical records on this claim, and has it been sent?” Often, the claim is denied simply because the doctor's office missed the deadline to fax the requested notes, a clerical error you can prevent by staying vigilant.

Has your genetic test or ER visit been stuck in “Pending” status for months? Leave a comment below—your story helps other readers know how long these manual reviews are really taking.